Lapchak

Lapchak v. Paradigm Biopharmaceuticals (USA), Inc.

Good Law
United States District Court, Southern District of CaliforniaFebruary 7, 20253:24-cv-00143California6,741 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 PAUL A. LAPCHAK, an individual, Case No.: 24-CV-143 JLS (DDL)

Plaintiff,

ORDER GRANTING DEFENDANTS’

v. MOTION TO DISMISS

PARADIGM BIOPHARMACEUTICALS (ECF No. 9) (USA), INC., a Delaware corporation; and 15 DONNA SKERRETT, an individual, 16 Defendants.

Presently before the Court are Defendants Paradigm Biopharmaceuticals (USA), Inc. (“Paradigm”) and Donna Skerrett’s (“Skerrett”) (collectively, “Defendants”) Motion to Dismiss Plaintiff’s First Amended Complaint’s Second, Third, and Fourth Causes of Action (“Mot.,” ECF No. 9) and Memorandum of Points and Authorities in Support Thereof (“Mem.,” ECF No. 9-1). Plaintiff Paul A. Lapchak filed an Opposition to the Motion (“Opp’n,” ECF No. 11), to which Defendants submitted a Reply (“Reply,” ECF No. 13). The Court took this matter under submission without oral argument pursuant to Civil Local Rule 7.1(d)(1) on June 27, 2024. ECF No. 12. Having carefully considered the Parties’…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.